Dr. ERIC DING is an epidemiologist, nutritionist, and clinical trialist at Harvard School of Public Health. He is also Director of Epidemiology with Microclinic International, and a Soros Fellow.
His work focuses on the intersection of randomized interventions for obesity/diabetes prevention, obesity/nutritional risk factors for chronic diseases, comparative risk and cost burdens, social networks on health behaviors, and social media technology for health. He has published in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, The Lancet, and Health Policy. His 75+ publications have received over 3800 external citations. As Director of Epidemiology at Microclinic International, he is the co-Principal Investigator of several randomized controlled trials of social network interventions against obesity and diabetes in the U.S. and abroad. Altogether, his competitively awarded research projects have been financed with over $8 million in funding.
A Google Tech Talk keynote speaker, a World Economic Forum Global Shaper, he has also served as: consultant for the World Health Organization, adviser to the European Commission (EC), moderator and planning committee member of the EC summit- FP7* Diabesity, advisor to the Slovenian Ministry of Health, judge for the annual VH1 Do Something Awards, and member of the WHO’s Global Burden of Disease Project and US Disease Burden Collaboration.
A cancer prevention advocate and childhood tumor survivor, he founded the online Campaign for Cancer Prevention, on Causes. In total online reach, he directs several health and disease prevention advocacy platforms, which together total 7 million members. In 2006, he was previously noted for his key role in leading a two-year-long investigation into the controversial drug safety and risks of Vioxx®, Celebrex®, and Bextra® that drew national FDA attention. Highlighted and express-published in JAMA, as chief corresponding author, he was recognized in the New York Times.
He was awarded the 2012 Outstanding Young Leader Award from the Boston Chamber of Commerce, and named among Craig Newmark’s “16 People and Organizations Changing the World in 2012”. His work was cited by the directors of CDC and CMMS in the framework of the “Million Hearts” initiative, and his research recognized twice as ‘Best of American Heart Association’. He has been featured in the Chronicle of Philanthropy, Newsweek, The New York Times, and profiled in books: CauseWired (Watson, Wiley & Sons, Inc 2008), Zilch (Lublin, Portfolio, Penguin Group 2010), and Shift & Reset (Reich, Wiley 2011). He was further awarded the Soros Fellowship in 2008.
Born in China and raised in diverse corners of the United States, he attended The Johns Hopkins University, graduating with Honors in Public Health and Phi Beta Kappa (junior year). He completed his dual doctorate in epidemiology and doctorate in nutrition at age 23 from Harvard University, and post-doctoral fellowship at the Harvard School of Public Health. At Harvard, he has taught more than a dozen graduate and undergraduate courses in global health, for which he received the Derek Bok Distinction in Teaching Award from Harvard College.
(*FP7 – European Commission’s 7th Framework Programme for Research and Technological Development)